title: [Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets].
abstract: Afobazole pharmacokinetics upon oral administration of tablets prepared according to various technologies was studied in rabbits. The main pharmacokinetic parameters were determined.
authors.forename: P O
authors.initials: PO
authors.lastname: Bochkov
authors.forename: A A
authors.initials: AA
authors.lastname: Litvin
authors.forename: G B
authors.initials: GB
authors.lastname: Kolyvanov
authors.forename: V P
authors.initials: VP
authors.lastname: Zherdev
authors.forename: E V
authors.initials: EV
authors.lastname: Blynskaia
authors.forename: L N
authors.initials: LN
authors.lastname: Grushevskaia
authors.forename: A A
authors.initials: AA
authors.lastname: Illarionov
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D001562:Benzimidazoles / Q000493:pharmacokinetics* / Q000494:pharmacology; D003692:Delayed-Action Preparations / Q000493:pharmacokinetics / Q000494:pharmacology; D008297:Male; D009025:Morpholines / Q000493:pharmacokinetics* / Q000494:pharmacology; D011817:Rabbits
chemical_list: C410924:2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole; D014151:Anti-Anxiety Agents; D001562:Benzimidazoles; D003692:Delayed-Action Preparations; D009025:Morpholines